Stem cell therapy for diabetes management using advanced MSC treatments to improve insulin sensitivity, reduce blood sugar levels, and manage diabetic complications effectively.
Stem cell therapy for diabetes mellitus at StemCell Longevita in Istanbul, Turkey offers a regenerative approach to improving insulin sensitivity, protecting remaining beta cells, and managing diabetic complications. Our mesenchymal stem cell (MSC) treatments using Wharton's jelly umbilical cord stem cells help both Type 1 and Type 2 diabetes patients improve metabolic markers and reduce medication dependence.
MSCs modulate the immune system to protect remaining insulin-producing beta cells from autoimmune destruction (particularly important in Type 1 diabetes). For Type 2 diabetes, MSCs improve insulin receptor sensitivity in peripheral tissues, reduce pancreatic inflammation, and promote beta cell regeneration. They also address diabetic complications by improving microvascular circulation, reducing neuropathy symptoms, and supporting kidney function. Published clinical trials show significant reductions in HbA1c and fasting blood glucose after MSC infusion.
Candidates include patients with Type 1 or Type 2 diabetes mellitus, particularly those with suboptimal glycemic control despite medication, diabetic complications (neuropathy, nephropathy, retinopathy), or those seeking to reduce insulin or oral medication dependence. Patients with pre-diabetes and metabolic syndrome may also benefit from early intervention.
After a free consultation and review of your HbA1c, fasting glucose, C-peptide levels, and metabolic panel, you travel to Istanbul for treatment. Pre-treatment evaluation includes comprehensive blood work and metabolic assessment. You receive IV infusion of 30-100 million MSCs in our accredited hospital. Treatment day is followed by 1-2 days of monitoring. The all-inclusive package covers your entire stay.
Most patients experience improved fasting blood glucose, reduced HbA1c levels (average 0.5-1.5% reduction), and improved C-peptide levels within 3-6 months. Many patients reduce their medication requirements. Diabetic neuropathy symptoms often improve within 2-4 months. Full metabolic benefits develop over 6-12 months with ongoing follow-up.
Turkey's advanced healthcare infrastructure, combined with significantly lower costs, makes Istanbul an ideal destination for diabetes stem cell therapy. Our GMP laboratory ensures cell quality exceeding international standards, while our medical team has treated hundreds of diabetic patients from 52+ countries.
Diabetes stem cell therapy starts from €6,950 at StemCell Longevita, including 30M+ MSCs, comprehensive metabolic evaluation, hotel accommodation, VIP transfers, and 12-month follow-up monitoring of metabolic markers. Save 50-85% versus US pricing.
Related treatments: Hepatitis Stem Cell Therapy | Liver Disease Stem Cell Therapy | COPD Stem Cell Therapy | Pulmonary Fibrosis Stem Cell Therapy | Kidney Disease Stem Cell Therapy
Pillar: stem cell therapy for liver disease in Istanbul
Related treatments: hepatitis stem cell treatment in Istanbul | diabetes stem cell therapy in Turkey | kidney disease MSC treatment in Istanbul | COPD stem cell therapy in Turkey
Research & guides: MSC therapy for diabetes management in Turkey | stem cell treatment for liver cirrhosis and fibrosis in Istanbul